Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fuji
Boehringer Ingelheim
Daiichi Sankyo
Farmers Insurance
McKinsey
Fish and Richardson
Covington
Teva

Generated: July 16, 2018

DrugPatentWatch Database Preview

FELBATOL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Felbatol patents expire, and what generic alternatives are available?

Felbatol is a drug marketed by Mylan Speciality Lp and is included in one NDA.

The generic ingredient in FELBATOL is felbamate. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the felbamate profile page.
Drug patent expirations by year for FELBATOL
Synonyms for FELBATOL
(3-aminocarbonyloxy-2-phenyl-propyl) carbamate
(3-carbamoyloxy-2-phenyl-propyl) carbamate
(3-carbamoyloxy-2-phenylpropyl) carbamate
1,3-Propanediol, 2-phenyl-, dicarbamate
2-?methyl-?4-?(4-?methyl-?1-?piperazinyl)-?10H-?thieno[2,?3-?b][1,?5]benzodiazepine
2-Phenyl-1,3-propanediol dicarbamate
2-Phenyl-1,3-propanedioldicarbamate
2-Phenylpropane-1,3-diyl dicarbamate
25451-15-4
3-(carbamoyloxy)-2-phenylpropyl carbamate
4-06-00-05993 (Beilstein Handbook Reference)
451F154
A817858
AB0011540
AB00382985_19
AB00382985-18
AB1008593
AC-8197
AC1L1FOW
ADD 03055
ADD-03055
AJ-26695
AK-90092
AKOS015895100
AN-4991
ANW-65602
AOB5042
API0002680
AX8130043
BDBM50088430
BIDD:GT0463
Biomol-NT_000203
BN0583
BPBio1_001258
BRD-K99107520-001-01-9
BRN 3345236
C-14192
C07501
C11H14N2O4
carbamic acid (3-carbamoyloxy-2-phenylpropyl) ester
carbamic acid 2-phenyltrimethylene ester
Carbamic acid 3-carbamoyloxy-2-phenyl-propyl ester
Carbamic acid, 2-phenyltrimethylene ester
CAS-25451-15-4
CC-28364
CCG-204614
CHEBI:4995
CHEMBL1094
CJ-24035
CS-2068
D00536
D05KON
DB00949
DR000557
DSSTox_CID_3041
DSSTox_GSID_23041
DSSTox_RID_76847
DTXSID9023041
EINECS 247-001-4
EN300-119542
Essex brand of felbamate
EU-0100524
EX-A591
F 0778
felbamate
Felbamate (USAN/INN)
Felbamate [USAN:INN]
Felbamate, United States Pharmacopeia (USP) Reference Standard
Felbamato
Felbamato [Spanish]
Felbamatum
Felbamatum [Latin]
Felbamyl
Felbatol (TN)
FT-0630517
GTPL5473
HMS2093P19
HMS2234H06
HMS3261J09
HMS3266L12
HMS3370I06
HMS3657I11
HSDB 7525
HY-B0184
I06-0353
J90036
K-6677
KB-232082
KS-00001F6O
KS-1171
Lopac-F-0778
Lopac0_000524
LP00524
LS-120706
MCULE-2661497722
MFCD00865296
MLS000028465
MLS001077299
MolPort-003-666-873
NCGC00015429-01
NCGC00015429-02
NCGC00015429-03
NCGC00015429-04
NCGC00015429-05
NCGC00015429-06
NCGC00015429-07
NCGC00015429-08
NCGC00015429-09
NCGC00015429-10
NCGC00015429-11
NCGC00015429-14
NCGC00023092-02
NCGC00023092-04
NCGC00023092-05
NCGC00023092-06
NCGC00255275-01
NCGC00261209-01
NSC-759866
NSC759866
Opera_ID_1738
OR248747
Pharmakon1600-01505600
Prestwick0_000919
Q-100326
s1330
SBB070639
SBI-0050507.P002
SC-46002
SCHEMBL34947
Schering brand of felbamate
Schering-Plough brand of felbamate
SMR000058448
Taloxa
TC-154347
Tocris-0869
Tox21_110145
Tox21_110145_1
Tox21_302368
Tox21_500524
UNII-X72RBB02N8
W 554
W-554
Wallace brand 1 of felbamate
Wallace brand 2 of felbamate
WKGXYQFOCVYPAC-UHFFFAOYSA-N
X72RBB02N8
Z1541638522
ZINC1530803

US Patents and Regulatory Information for FELBATOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp FELBATOL felbamate SUSPENSION;ORAL 020189-003 Jul 29, 1993 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-001 Jul 29, 1993 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for FELBATOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp FELBATOL felbamate SUSPENSION;ORAL 020189-003 Jul 29, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-001 Jul 29, 1993 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Citi
Harvard Business School
Fuji
Teva
Dow
Johnson and Johnson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.